- Home
- DXR vs SACH Comparison
DXR vs SACH Comparison
Compare DXR & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXR | SACH |
|---|---|---|
| Founded | 1970 | 2010 |
| Country | United States | United States |
| Employees | N/A | 27 |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 57.5M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | DXR | SACH |
|---|---|---|
| Price | $10.45 | $0.80 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 1.8K | ★ 133.3K |
| Earning Date | 02-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 19.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,446,345.00 | N/A |
| Revenue This Year | $44,935.22 | $145.00 |
| Revenue Next Year | $74.79 | $6.80 |
| P/E Ratio | $33.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.56 | $0.80 |
| 52 Week High | $14.76 | $1.45 |
Technical Indicators
Market Signals| Indicator | DXR | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 50.38 | 26.77 |
| Support Level | $9.35 | N/A |
| Resistance Level | $10.91 | $1.12 |
| Average True Range (ATR) | 0.37 | 0.03 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 20.83 | 1.87 |
Price Performance
Historical ComparisonAbout DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.